Published online before print August 26, 2002, doi: 10.1161/01.CIR.0000028811.03056.BF
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2002;106:1530.)
© 2002 American Heart Association, Inc.
Basic Science Reports |
Protective Function of Transcription Factor TR3 Orphan Receptor in Atherogenesis
Decreased Lesion Formation in Carotid Artery Ligation Model in TR3 Transgenic Mice
From the Department of Biochemistry (E.K.A., V.d.W., M.v.B., T.A.E.v.A., H.P., C.J.M.d.V.), Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands; Gaubius Laboratory (J.M.G.), Leiden, the Netherlands; and ULB-IBMM-IRIBHN (B.P.), Gosselies, Belgium.
Correspondence to C.J.M. de Vries, PhD, Department of Biochemistry, Academic Medical Center, K1-163, Meibergdreef 15, 1105 AZ Amsterdam, Netherlands. E-mail c.j.devries@ amc.uva.nl
Background— Smooth muscle cells (SMCs) play a key role in intimal thickening in atherosclerosis and restenosis. The precise signaling pathways by which the proliferation of SMCs is regulated are largely unknown. The TR3 orphan receptor, the mitogen-induced nuclear orphan receptor (MINOR), and the nuclear receptor of T cells (NOT) are a subfamily of transcription factors belonging to the nuclear receptor superfamily and are induced in activated SMCs. In this study, we investigated the role of these transcription factors in SMC proliferation in atherogenesis.
Methods and Results— Multiple human vascular specimens at distinct stages of atherosclerosis (lesion types II to V by American Heart Association classification) derived from 14 different individuals were studied for expression of these transcription factors. We observed expression of TR3, MINOR, and NOT in neointimal SMCs, whereas no expression was detected in medial SMCs. Adenovirus-mediated expression of a dominant-negative variant of TR3, which suppresses the transcriptional activity of each subfamily member, increases DNA synthesis and decreases p27Kip1 protein expression in cultured SMCs. We generated transgenic mice that express this dominant-negative variant or full-length TR3 under control of a vascular SMC-specific promoter. Carotid artery ligation of transgenic mice that express the dominant-negative variant of TR3 in arterial SMCs, compared with lesions formed in wild-type mice, results in a 3-fold increase in neointimal formation, whereas neointimal formation is inhibited 5-fold in transgenic mice expressing full-length TR3.
Conclusions— Our results reveal that TR3 and possibly other members of this transcription factor subfamily inhibit vascular lesion formation. These transcription factors could serve as novel targets in the treatment of vascular disease.
Key Words: muscle, smooth • atherosclerosis • genes
This article has been cited by other articles:
 |
|
 |
|
  M. A. Pearen, S. A. Myers, S. Raichur, J. G. Ryall, G. S. Lynch, and G. E. O. Muscat The Orphan Nuclear Receptor, NOR-1, a Target of {beta}-Adrenergic Signaling, Regulates Gene Expression that Controls Oxidative Metabolism in Skeletal Muscle Endocrinology, June 1, 2008; 149(6): 2853 - 2865. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. C. Chao, Z. Zhang, L. Pei, T. Saito, P. Tontonoz, and P. F. Pilch Nur77 Coordinately Regulates Expression of Genes Linked to Glucose Metabolism in Skeletal Muscle Mol. Endocrinol., September 1, 2007; 21(9): 2152 - 2163. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. M.M. Pires, T. W.H. Pols, M. R. de Vries, C. M. van Tiel, P. I. Bonta, M. Vos, E. K. Arkenbout, H. Pannekoek, J. W. Jukema, P. H.A. Quax, et al. Activation of Nuclear Receptor Nur77 by 6-Mercaptopurine Protects Against Neointima Formation Circulation, January 30, 2007; 115(4): 493 - 500. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. I. Bonta, C. M. van Tiel, M. Vos, T. W.H. Pols, J. V. van Thienen, V. Ferreira, E. K. Arkenbout, J. Seppen, C. A. Spek, T. van der Poll, et al. Nuclear Receptors Nur77, Nurr1, and NOR-1 Expressed in Atherosclerotic Lesion Macrophages Reduce Lipid Loading and Inflammatory Responses Arterioscler. Thromb. Vasc. Biol., October 1, 2006; 26(10): 2288 - 2288. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Schepers, D. Eefting, P.I. Bonta, J.M. Grimbergen, M.R. de Vries, V. van Weel, C.J. de Vries, K. Egashira, J.H. van Bockel, and P.H.A. Quax Anti-MCP-1 Gene Therapy Inhibits Vascular Smooth Muscle Cells Proliferation and Attenuates Vein Graft Thickening Both In Vitro and In Vivo Arterioscler. Thromb. Vasc. Biol., September 1, 2006; 26(9): 2063 - 2069. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. de Waard, E. K. Arkenbout, M. Vos, A. I.M. Mocking, H. W.M. Niessen, W. Stooker, B. A.J.M. de Mol, P. H.A. Quax, E. N.T.P. Bakker, E. VanBavel, et al. TR3 Nuclear Orphan Receptor Prevents Cyclic Stretch-Induced Proliferation of Venous Smooth Muscle Cells Am. J. Pathol., June 1, 2006; 168(6): 2027 - 2035. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Pei, A. Castrillo, and P. Tontonoz Regulation of Macrophage Inflammatory Gene Expression by the Orphan Nuclear Receptor Nur77 Mol. Endocrinol., April 1, 2006; 20(4): 786 - 794. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Pei, A. Castrillo, M. Chen, A. Hoffmann, and P. Tontonoz Induction of NR4A Orphan Nuclear Receptor Expression in Macrophages in Response to Inflammatory Stimuli J. Biol. Chem., August 12, 2005; 280(32): 29256 - 29262. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Crespo, J. Martinez-Gonzalez, J. Rius, and L. Badimon Simvastatin inhibits NOR-1 expression induced by hyperlipemia by interfering with CREB activation Cardiovasc Res, August 1, 2005; 67(2): 333 - 341. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Ralph, A. N. McEvoy, D. Kane, B. Bresnihan, O. FitzGerald, and E. P. Murphy Modulation of Orphan Nuclear Receptor NURR1 Expression by Methotrexate in Human Inflammatory Joint Disease Involves Adenosine A2A Receptor-Mediated Responses J. Immunol., July 1, 2005; 175(1): 555 - 565. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K D S. A. Wansa and G. E O Muscat TRAP220 is modulated by the antineoplastic agent 6-Mercaptopurine, and mediates the activation of the NR4A subgroup of nuclear receptors J. Mol. Endocrinol., June 1, 2005; 34(3): 835 - 848. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Martinez-Gonzalez and L. Badimon The NR4A subfamily of nuclear receptors: new early genes regulated by growth factors in vascular cells Cardiovasc Res, February 15, 2005; 65(3): 609 - 618. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Bassett, T. Suzuki, H. Sasano, C. J. M. de Vries, P. T. Jimenez, B. R. Carr, and W. E. Rainey The Orphan Nuclear Receptor NGFIB Regulates Transcription of 3{beta}-Hydroxysteroid Dehydrogenase: IMPLICATIONS FOR THE CONTROL OF ADRENAL FUNCTIONAL ZONATION J. Biol. Chem., September 3, 2004; 279(36): 37622 - 37630. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Lammi, J. Huppunen, and P. Aarnisalo Regulation of the Osteopontin Gene by the Orphan Nuclear Receptor NURR1 in Osteoblasts Mol. Endocrinol., June 1, 2004; 18(6): 1546 - 1557. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Rius, J. Martinez-Gonzalez, J. Crespo, and L. Badimon Involvement of Neuron-Derived Orphan Receptor-1 (NOR-1) in LDL-Induced Mitogenic Stimulus in Vascular Smooth Muscle Cells: Role of CREB Arterioscler. Thromb. Vasc. Biol., April 1, 2004; 24(4): 697 - 702. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. K. Arkenbout, M. van Bragt, E. Eldering, C. van Bree, J. M. Grimbergen, P. H.A. Quax, H. Pannekoek, and C. J.M. de Vries TR3 Orphan Receptor Is Expressed in Vascular Endothelial Cells and Mediates Cell Cycle Arrest Arterioscler. Thromb. Vasc. Biol., September 1, 2003; 23(9): 1535 - 1540. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. D. S. A. Wansa, J. M. Harris, G. Yan, P. Ordentlich, and G. E. O. Muscat The AF-1 Domain of the Orphan Nuclear Receptor NOR-1 Mediates Trans-activation, Coactivator Recruitment, and Activation by the Purine Anti-metabolite 6-Mercaptopurine J. Biol. Chem., June 27, 2003; 278(27): 24776 - 24790. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Gruber, P. Hufnagl, R. Hofer-Warbinek, J. A. Schmid, J. M. Breuss, R. Huber-Beckmann, M. Lucerna, N. Papac, H. Harant, I. Lindley, et al. Direct binding of Nur77/NAK-1 to the plasminogen activator inhibitor 1 (PAI-1) promoter regulates TNFalpha -induced PAI-1 expression Blood, April 15, 2003; 101(8): 3042 - 3048. [Abstract] [Full Text] [PDF]
|
|